Stage 2 · Toolkit 2.4
Safety Pharmacology Program
Assess safety pharmacology risks, including cardiovascular, respiratory, and CNS risk.
What it helps control
Operational support
Helps teams establish the procedures, working records, trackers, and evidence needed for Safety Pharmacology Program.
How it helps your team
Surface evidence gaps and dependencies before they delay IND, CTA, or first-in-human decisions.
Designed for
Nonclinical development, toxicology, safety pharmacology, bioanalysis, Regulatory Affairs, and Quality teams.
Included files
Know exactly what the toolkit contains
The file names below show what is included. File contents become available only after purchase.
Word documents
- Safety Pharmacology Strategy Plan
- Safety Pharmacology Study Protocol Template
- Safety Pharmacology Report Review Checklist
- Safety Pharmacology Risk Assessment
- Safety Pharmacology Key Finding Summary
- Safety Pharmacology Decision Memo
Excel workbooks
- Safety Pharmacology Study Tracker
- Safety Pharmacology Findings Tracker
- Risk Signal Tracker
- Safety Pharmacology Evidence Matrix
- Source Data Reference Log
Related toolkits
Continue within stage 2
Nonclinical Development Plan & IND/CTA-Enabling Strategy
Define the nonclinical package needed to support IND, CTA, first-in-human, and clinical development.
2.2GLP Compliance & Sponsor Oversight
Ensure GLP studies are appropriately planned, overseen, monitored, documented, reported, and archived.
2.3Toxicology Study Planning & Management
Manage toxicology studies and interpret key findings for regulatory and FIH readiness.